BY-O1A
BY-O1A
BY-O1A
BY-O1A
BY-O1A
BY-O1A
BY-O1A
BY-O1A
BY-O1A
BY-O1A
BY-O1A
BY-O1A
BY-O1A
BY-O1A
2024

Share:

BY-O1A

An ophthalmic examination device

BY-O1A is an ophthalmic examination device designed for thyroid-associated ophthalmopathy. It utilizes real-time data analysis, AI diagnosis, various imaging techniques, and personalized medical advice technology to achieve multifactorial and precise detection of ocular lesions, enhancing diagnostic accuracy and efficiency. With cloud storage and network connection, it enhances data integrity, security, and sharing. Upgrades and maintenance allow the device to be consistently effective and efficient.

Client / Manufacturer

BaiYiHealthcare Technology Co.,Ltd

Shanghai, CN
Design

BaiYiHealthcare Technology Co.,Ltd

Shanghai, CNTian Chaonan, Du Dong, Xiong Mengyingjing

Shanghai Institute of Endocrine and Metabolic Diseases

Shanghai, CNWang Weiqing, Shen Liyun
Date of Launch
2024
Development Time
up to 6 Month
Target Regions
Africa, Asia, Australia / Oceania, Europe, North America, South America
Target Groups
Consumers / Users

RELATED PROJECTS